| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |